8-K
Current Report
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-24-070883
Shareholder rights changed · Bylaws or fiscal year change · Other events
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading ea021179601-8k_cadrenal.htm…